These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8518414)

  • 1. Retinoids and tamoxifen in breast cancer chemoprevention.
    Costa A; Sacchini V; Decensi A
    Int J Clin Lab Res; 1993; 23(2):53-5. PubMed ID: 8518414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer chemoprevention.
    Costa A
    Eur J Cancer; 1993; 29A(4):589-92. PubMed ID: 8382073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition of human in vitro and mouse in vitro and in vivo mammary tumor models by retinoids in comparison with tamoxifen and the RU-486 anti-progestagen.
    Darro F; Cahen P; Vianna A; Decaestecker C; Nogaret JM; Leblond B; Chaboteaux C; Ramos C; Pétein M; Budel V; Schoofs A; Pourrias B; Kiss R
    Breast Cancer Res Treat; 1998 Sep; 51(1):39-55. PubMed ID: 9877028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective estrogen receptor modulators (SERMs) and retinoids in breast cancer chemoprevention.
    Zujewski J
    Environ Mol Mutagen; 2002; 39(2-3):264-70. PubMed ID: 11921197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary retinoids and carotenoids in rodent models of mammary tumorigenesis.
    Moon RC; Constantinou AI
    Breast Cancer Res Treat; 1997; 46(2-3):181-9. PubMed ID: 9478273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials with retinoids for breast cancer chemoprevention.
    Zanardi S; Serrano D; Argusti A; Barile M; Puntoni M; Decensi A
    Endocr Relat Cancer; 2006 Mar; 13(1):51-68. PubMed ID: 16601279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of breast cancer.
    De Palo G; Costa A; Formelli F; Del Vecchio M; Marubini E; Veronesi U
    In Vivo; 1993; 7(6B):577-80. PubMed ID: 8193278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factors-beta are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system.
    Zujewski J; Vaughn-Cooke A; Flanders KC; Eckhaus MA; Lubet RA; Wakefield LM
    Breast Cancer Res; 2001; 3(1):66-75. PubMed ID: 11250748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The retinoids and cancer prevention mechanisms.
    Dragnev KH; Rigas JR; Dmitrovsky E
    Oncologist; 2000; 5(5):361-8. PubMed ID: 11040271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of breast cancer.
    Osborne MP
    Surg Clin North Am; 1999 Oct; 79(5):1207-21. PubMed ID: 10572559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacological manipulation of members of the transforming growth factor beta family in the chemoprevention of breast cancer.
    Dickens TA; Colletta AA
    Bioessays; 1993 Jan; 15(1):71-4. PubMed ID: 8466478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer.
    Decensi A; Costa A
    Eur J Cancer; 2000 Apr; 36(6):694-709. PubMed ID: 10762741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks and benefits of retinoids in the chemoprevention of cancer.
    de Palo G; Formelli F
    Drug Saf; 1995 Oct; 13(4):245-56. PubMed ID: 8573297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current methods to prevent the development of breast cancer.
    Cristofanilli M; Hortobagyi GN
    In Vivo; 1998; 12(6):659-65. PubMed ID: 9891229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic retinoid fenretinide in breast cancer chemoprevention.
    Bonanni B; Lazzeroni M; Veronesi U
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):423-32. PubMed ID: 17428163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An appraisal of strategies to reduce the incidence of breast cancer.
    Jordan VG; Morrow M
    Stem Cells; 1993 Jul; 11(4):252-62. PubMed ID: 8401248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of breast cancer with fenretinide.
    Torrisi R; Decensi A; Formelli F; Camerini T; De Palo G
    Drugs; 2001; 61(7):909-18. PubMed ID: 11434448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention. Strategies for the control of cancer.
    Lippman SM; Benner SE; Hong WK
    Cancer; 1993 Aug; 72(3 Suppl):984-90. PubMed ID: 8334674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoids as cancer-preventive agents.
    Sankaranarayanan R; Mathew B
    IARC Sci Publ; 1996; (139):47-59. PubMed ID: 8923019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of breast cancer chemoprevention.
    Chang JC
    Biomed Pharmacother; 1998; 52(3):133-6. PubMed ID: 9755806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.